De novo variant of CSNK2B causes Poirier-Bienvenu neurodevelopmental syndrome: two case report.
10.3760.cma.j.cn511374-20210902-00717
- Author:
Jia ZHANG
1
;
Yang LI
;
Huan LUO
;
YaJun SHEN
;
Meng YUAN
;
Zuozhen YANG
;
Jing GAN
Author Information
1. Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China. gordonrachel@scu.edu.cn.
- Publication Type:Journal Article
- MeSH:
Child;
DNA Copy Number Variations;
Developmental Disabilities/genetics*;
Epilepsy/genetics*;
Humans;
Intellectual Disability/genetics*;
Seizures/genetics*
- From:
Chinese Journal of Medical Genetics
2022;39(5):484-487
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the clinical characteristics and CSNK2B gene variant of 2 children with Poirier-Bienvenu neurodevelopmental syndrome, and to identify the possible pathogenic causes and provide evidence for clinical diagnosis.
METHODS:Two children with Poirier-Bienvenu neurodevelopmental syndrome were selected from West China Second University Hospital, Sichuan University. The clinical manifestations, laboratory examination and CSNK2B gene variant were analyzed.
RESULTS:The main manifestations of 2 children were epilepsy, motor or intellectual retardation. Whole exon sequencing showed that CSNK2B gene c. 291+4A>T heterozygous splicing variant was found in case one, and CSNK2B copy number variation(CNV) was lost in case two. Case one received no special treatment, followed up for 8+ months, seizures and motor development were improved; case two had recurrent seizures for 9+ years, and received levetiracetam and clonazepam antiepileptic treatment. No seizures have occurred for 2 years now, and a large number of epileptic discharges can still be seen in video electroencephalogram (VEEG) with slightly backward intelligence and language development.
CONCLUSION:Our study further proves that the pathogenic variant of CSNK2B is related to epilepsy with developmental disorder, and enrich is the CSNK2B gene variant spectrum. The pathogenesis of CSNK2B has great clinical heterogeneity, with great difference in severity of nervous system injury and different prognosis, and agenesis of corpus callosum may be one of its clinical phenotypes.
